Delivery Order SPE2DB20D3103-SPE2DB23FN6B3
- Not listed
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops with a 3ml volume, valued at $5,616.54. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Vigamox 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,828.03 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,727.14 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 9, 2022, with a completion date of December 12, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops in 3ml quantities to the Medical Supply Chain, which is an organization under the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 24, 2024, with a ceiling value of $2,218.40. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 25, 2024. This...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 18, 2024, with a ceiling value of $3,104.66 and a completion date of July 19, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award is for the delivery of Vigamox 0.5% eye drops (3ml) to the Defense Logistics Agency (DLA). The $1,590.43 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $2,662.08 and is a delivery order with a firm fixed price. It was awarded on April 15, 2024 with an ultimate completion date of April 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery...
- This federal contract award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $12,422.06 and has a firm fixed price pricing type. The award date is May 26, 2022, and the ultimate completion date is May 27, 2022. The contract is not designated with a set-aside....
- This federal contract award, valued at $1,699.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $5,016.28 for the procurement of Vigamox 0.5% eye drops. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. The contract is for the delivery of a wide...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN6B3Delivery Order
This federal contract award is for the delivery of VIGAMOX 0.5% eye drops (3 ml) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has a ceiling value of $10,167.60 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen Drug Corp's role as a critical supplier of essential medical commodities to the Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 6/5/23 |